The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the study involved 32 confirmed koba 19 patients who were administered 600 milligrams of hydroxychloroquine daily for six days some patients also receive the antibiotic azithromycin nasal pharyngeal samples were taken on day 6 of the treatment and it indicated that 70% of the hydroxychloroquine treated patients had cleared the virus compared to 12.5% in the group receiving standard of care
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.